We are developing a proprietary class of engineered B cell medicines to unleash the power of cell therapies beyond cell-cell contact-dependent killing (e.g., CAR-T cells). As the centerpiece of the body’s non-contact dependent humoral immune system, B cells offer a platform for cell therapy that can secrete large amounts of diverse molecular cargo in a […]
There is no excerpt because this is a protected post.
Coming Soon… Executive Level Sales and Marketing – Commercial Launch For a preview discussion, please contact me firstname.lastname@example.org
TSE is pleased to announce a partnership with several early stage (pre-IPO) but well funded companies in the AAV Gene Therapy space in Boston and Cambridge, MA, NYC, Philadelphia and San Francisco Open positions will be created and posted soon but will include: CSO S/VP Head of Translational Biology CMO Head of Clinical Development Director, […]
We have been fortunate to work closely with a global biopharma to help build their commercial strategy team. We are fortunate to work with companies making a meaningful difference in the fight to end cancer. This company is building their global strategy as they move Immuno-Oncology therapies to market. Contact us email@example.com to help build […]
After a recruiting journey with candidates from Europe, Asia and all over the US, I am happy to announce that our client Grace Science, LLC has selected a Bay Area local to lead their ambitious R&D effort in Gene Editing/Gene Therapy, Rare Diseases, Neuromuscular and Oncology. It has been a privilege to work with the […]
I am thrilled to announce that after fewer than 5 weeks, we have had two VP roles have offers accepted for a rare disease client in the San Francisco Bay Area. This was a national search bringing VP level talent from powerhouse commercial pharmaceutical companies to a company preparing to launch multiple assets. To view […]